Adello Biologics' Series A Round

Adello Biologics raised a round of funding on July 20, 2010. Investors include Capital Midwest Fund.

Adello, formerly Therapeutic Proteins International, is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The com…

Articles about Adello Biologics' Series A Round: